How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group

How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group

Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and daily routine around the world. Huge efforts from pharmacological industries have led to the development of COVID-19 vaccines. In particular two mRNA vaccines, namely the BNT162b2 (Pfizer-BioNTech) and the mRNA-12...

Full description

Bibliographic Details
Main Authors: Francesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, Stefania Carmagnola, Emilio Clementi, Piergiorgio Danelli, Dario Dilillo, Paolo Fiorina, Massimo Galli, Maurizio Gallieni, Giovanni Genovese, Valeria Giorgi, Alessandro Invernizzi, Giovanni Maconi, Jeanette A. Maier, Angelo V. Marzano, Paola S. Morpurgo, Manuela Nebuloni, Dejan Radovanovic, Agostino Riva, Giuliano Rizzardini, Gianmarco Sabiu, Pierachille Santus, Giovanni Staurenghi, Gianvincenzo Zuccotti, Pier Carlo Sarzi-Puttini, Sandro Ardizzone
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
COVID-19
Sars-CoV-2
vaccine
IMIDs
chronic disease
prevention
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.656362/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.656362/full

Similar Items